1 / 3

Some facts about Indian Pharma

Some facts about Indian Pharma. The Indian pharmaceutical industry is currently worth $6.5 billion and growing at 8-10% annually, It is the 4th largest pharmaceutical industry in the world , and is expected to be worth $12 billion by 2008. Its exports are over $2 billion.

ofira
Télécharger la présentation

Some facts about Indian Pharma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Some facts about Indian Pharma • The Indian pharmaceutical industry is currently worth $6.5 billion and growing at 8-10% annually, • It is the 4th largest pharmaceutical industry in the world, and is expected to be worth $12 billion by 2008. • Its exports are over $2 billion. • India is among the top five bulk drug makers and at home, the local industry has edged out the Multi-National companies whose share of 75% in the market is down to 35%. • Trade of medicinal plants has crossed $900M already. GLOBAL PRESPECTIVE ON PHARMA & BIOTECH

  2. Some facts about Indian BT • There are 170 biotechnology companies in India, involved in the development and manufacture of genomic drugs, whose business is growing exponentially. • Sequencing genes and delivering genomic information for big Pharmaceutical companies is the next boom industry in India. • So truly formulated by our Respected Chief Minister • Shri Narendra Modi • BT +BT=BT • India is poised to revolutionise biotechnology just as it did the IT industry. • -The Economic Times GLOBAL PRESPECTIVE ON PHARMA & BIOTECH

  3. Pillars to pharma and biotech success Intellectual Property & Protection Capital formation Access to market GLOBAL PRESPECTIVE ON PHARMA & BIOTECH

More Related